Clinical Trial

Acetyl-leucine in Post-stroke Ataxia

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 10, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Along with the current clinical trial, the efficacy and safety of 4 gram of acetyl-leucine daily for three months in patients with post-stroke ataxia following posterior-circulation ischaemic stroke assessed through BBS, SARA, and mRS, and possible adverse effects.
Trial Details
NCT Number NCT07275749
Lead Sponsor Kafrelsheikh University
Conditions Ischemic Stroke
Enrollment 200 participants
Start Date 2025-12-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-20 (estimated)
Updated on ClinicalTrials.gov 2025-12-10